Urologists a Key Factor in PCa Observation Underuse

April 2013
Renal & Urology News;Apr2013, Vol. 12 Issue 4, p16
The article reports on the study conducted by Karen E. Hoffman of The University of Texas and colleagues which suggests that older men with favorable-risk prostate cancer (PCa) can be managed safely with observation by the diagnosing urologist.


Related Articles

  • Fewer Men Being Screened for Prostate Cancer. Norton, Amy // Tennessee Tribune;11/26/2015, Vol. 26 Issue 48, p8B 

    The article reports on the decline in incidence and the decline in the proportion of men who are diagnosed with prostate cancer in the U.S.

  • Prostate cancer patient's survival in Lithuania. Smailytė, Giedrė; Adomaitis, Robertas; Ulinskas, Karolis; Aleknavičienė, Birutė // Acta Medica Lituanica;2012, Vol. 19 Issue 4, p439 

    Background. The aim of this study was to evaluate changes in the survival of prostate cancer patients during the 12-year period and to analyze differences in survival by period of diagnosis, stage of disease, age and place of residence. Materials and methods. All newly diagnosed cases of...

  • Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Thörmer, Gregor; Otto, Josephin; Reiss-Zimmermann, Martin; Seiwerts, Matthias; Moche, Michael; Garnov, Nikita; Franz, Toni; Do, Minh; Stolzenburg, Jens-Uwe; Horn, Lars-Christian; Kahn, Thomas; Busse, Harald // European Radiology;Aug2012, Vol. 22 Issue 8, p1820 

    Objectives: To evaluate the influence of the choice of b values on the diagnostic value of the apparent diffusion coefficient (ADC) for detection and grading of prostate cancer (PCa). Methods: Forty-one patients with biopsy-proven PCa underwent endorectal 3-T MRI before prostatectomy. Different...

  • Tumor Size Predicts Biochemical Recurrence Risk.  // Renal & Urology News;Jul2014, Vol. 13 Issue 7, p25 

    The article offers information on a study which discusses the use of maximal tumor diameter (MTD) to predict risk of prostate-specific antigen (PSA) failure among patients.

  • New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma. Szwed, Ellen A.; Sliesoraitis, Sarunas; Nguyen, Thu-Cuc; Nguyen, Minh-Nguyet; Moreb, Jan S.; Zlotecki, Robert A.; Crispen, Paul L.; Dang, Nam H.; Dang, Long H. // Case Reports in Oncological Medicine;2/19/2015, Vol. 2015, p1 

    In the management of patients with prostate cancer, the development of new radiographic findings can mimic progression of the disease, thereby triggering changes in treatment. Typically, clinicians evaluate additional parameters, such as symptoms and prostate specific antigen (PSA) levels, for...

  • Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients. McArthur, C.; McLaughlin, G.; Meddings, R. N. // British Journal of Radiology;Apr2012, Vol. 85 Issue 1012, p390 

    Objectives: The aim of this study was to correlate the prostate-specific antigen (PSA) level and Gleason score with staging bone scan result in patients with a new diagnosis of prostate cancer in order to establish the feasibility of implementing the European Association Urology guidelines,...

  • CULTURAL BELIEFS AND ATTITUDES OF AFRICAN AMERICAN PROSTATE CANCER SURVIVORS. Jones, Randy; Taylor, Ann; Bourguignon, Cheryl; Steeves, Richard; Theodorescu, Dan; Kilbridge, Kerry // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p414 

    Cultural beliefs play a major role in the stage of prostate cancer at which African Americans are at higher risk to be diagnosed. These beliefs may assist in the decision for acceptable treatments. To provide culturally sensitive care, healthcare professionals must be aware of these beliefs....

  • Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: A comparative evaluation at the same Institution. Cerruto, Maria Angela; Vianello, Fabio; D'Elia, Carolina; Artibani, Walter; Novella, Giovanni // Archivio Italiano di Urologia, Andrologia: Organo Ufficiale di S;2014, Vol. 86 Issue 4, p284 

    Background: The ideal bioptic strategy for CaP detection is still to be completely defined. The aim of our study is to compare transperineal (TP) and transrectal (TR) approaches, in a 14-core initial prostate biopsy for CaP detection. Material and methods: A prospective controlled study was...

  • The Effectiveness of transperineal template guided mapping biopsy compared to transrectal ultrasound guided biopsy in detecting prostate cancer. Dunne, R. S.; Bouchier-Hayes, D. M. // BMC Proceedings;1/14/2015, p1 

    A conference paper about impact of transperineal template guided mapping biopsy (TTMB) in comparisons to transrectal ultrasound guided biopsy (TRUS) in detecting prostate cancer and mentions that TTMB can be used as a step in the management pathway of patients with suspected prostate cancer.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics